168 related articles for article (PubMed ID: 30112220)
1. Erythema Dyschromicum Perstans in an 8-Year-Old Indian Child.
Leung AKC; Lam JM
Case Rep Dermatol Med; 2018; 2018():2143089. PubMed ID: 30112220
[TBL] [Abstract][Full Text] [Related]
2. Periorbital hyperpigmentation and erythema dyschromicum perstans.
Ing EB; Buncic JR; Weiser BA; de Nanassy J; Boxall L
Can J Ophthalmol; 1992 Dec; 27(7):353-5. PubMed ID: 1490247
[TBL] [Abstract][Full Text] [Related]
3. Erythema dyschromicum perstans and vitiligo.
Naik NS
Dermatol Online J; 2003 Oct; 9(4):25. PubMed ID: 14594598
[TBL] [Abstract][Full Text] [Related]
4. Erythema dyschromicum perstans in children: a report of 14 cases.
Torrelo A; Zaballos P; Colmenero I; Mediero IG; de Prada I; Zambrano A
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):422-6. PubMed ID: 15987286
[TBL] [Abstract][Full Text] [Related]
5. Erythema dyschromicum perstans in prepubertal children.
Silverberg NB; Herz J; Wagner A; Paller AS
Pediatr Dermatol; 2003; 20(5):398-403. PubMed ID: 14521555
[TBL] [Abstract][Full Text] [Related]
6. [Erythema dyschromicum perstans versus lichen planus].
Leonforte JL; Peláez de di Bari O
Med Cutan Ibero Lat Am; 1987; 15(1):89-92. PubMed ID: 3298889
[TBL] [Abstract][Full Text] [Related]
7. Erythema dyschromicum perstans in a child following an enteroviral meningitis.
Melo CR; Sá MC; Carvalho S
An Bras Dermatol; 2017; 92(1):137-138. PubMed ID: 28225976
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy.
Baranda L; Torres-Alvarez B; Cortes-Franco R; Moncada B; Portales-Perez DP; Gonzalez-Amaro R
Arch Dermatol; 1997 Mar; 133(3):325-9. PubMed ID: 9080892
[TBL] [Abstract][Full Text] [Related]
9. [Erythema dyschromicum perstans].
Möller-Vietheer M; Goos M
Hautarzt; 1977 Oct; 28(10):539-41. PubMed ID: 340421
[TBL] [Abstract][Full Text] [Related]
10. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
11. Erythema Dyschromicum Perstans: Response to Topical Tacrolimus.
Mahajan VK; Chauhan PS; Mehta KS; Sharma AL
Indian J Dermatol; 2015; 60(5):525. PubMed ID: 26538750
[TBL] [Abstract][Full Text] [Related]
12. Erythema dyschromicum perstans in early childhood.
Lee SJ; Chung KY
J Dermatol; 1999 Feb; 26(2):119-21. PubMed ID: 10091483
[TBL] [Abstract][Full Text] [Related]
13. Erythema dyschromicum perstans showing resolution in an adult.
Antonov NK; Braverman I; Subtil A; Halasz CL
JAAD Case Rep; 2015 Jul; 1(4):185-7. PubMed ID: 27051725
[No Abstract] [Full Text] [Related]
14. Coexistence of erythema dyschromicum perstans and vitiligo: a case report and review of the literature.
Tamer F
Acta Dermatovenerol Alp Pannonica Adriat; 2016 Dec; 25(4):77-78. PubMed ID: 28006880
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series.
Diaz A; Gillihan R; Motaparthi K; Rees A
JAAD Case Rep; 2020 Mar; 6(3):207-213. PubMed ID: 32149180
[No Abstract] [Full Text] [Related]
16. Erythema dyschromicum perstans and lichen planus.
Naidorf KF; Cohen SR
Arch Dermatol; 1982 Sep; 118(9):683-5. PubMed ID: 7114873
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor-induced erythema dyschromicum perstans-like pigmentation.
Gutierrez D; Krueger LD; Tan A; Park JH; Lipkin G; Meehan SA
JAAD Case Rep; 2019 Aug; 5(8):701-703. PubMed ID: 31440561
[No Abstract] [Full Text] [Related]
18. Erythema dyschromicum perstans: response to dapsone therapy.
Bahadir S; Cobanoglu U; Cimsit G; Yayli S; Alpay K
Int J Dermatol; 2004 Mar; 43(3):220-2. PubMed ID: 15009398
[TBL] [Abstract][Full Text] [Related]
19. Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment.
Wolfshohl JA; Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):60-62. PubMed ID: 27552666
[TBL] [Abstract][Full Text] [Related]
20. Erythema Dyschromicum Perstans: Identical to Ashy Dermatosis or Not?
Numata T; Harada K; Tsuboi R; Mitsuhashi Y
Case Rep Dermatol; 2015; 7(2):146-50. PubMed ID: 26351421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
